EUVIMEDEUVIMED entdecken
Crossref

Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy

Yi Wang, Sheng-Lin Qiao, Jie Wang, Meng-Zhen Yu, Nan-Nan Wang, Muhetaerjiang Mamuti, Hong-Wei An, Yao-Xin Lin iD, Hao Wang

Advanced Materials · 2024

DOI: 10.1002/adma.202306248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, P…. Hauptthemen laut MEDLINE: Autophagy, Immunotherapy, Toll-Like Receptor 9, Nanostructures. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Programs of the Ministry of Science and Technology, National Center for Nanoscience and Technology and Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Smart nanorobots have emerged as novel drug delivery platforms in nanomedicine, potentially improving anti‐cancer efficacy and reducing side effects. In this study, an intelligent tumor microenvironment‐responsive nanorobot is developed that effectively delivers CpG payloads to Toll‐like receptor 9 (TLR9)‐positive tumors to induce autophagy‐mediated cell death for immunotherapy. The nanorobots are fabricated by co‐self‐assembly of two amphiphilic triblock polymer peptides: one containing the matrix metallopeptidase 2 (MMP2)‐cleaved GPLGVRGS motif to control the mechanical opening of the nanorobots and provide targeting capability for TLR‐9‐positive tumors and the other consisting of an arginine‐rich GRRRDRGRS sequence that can condense nuclear acid payloads through electrostatic interactions. Using multiple tumor‐bearing mouse models, it is investigated whether the intravenous injection of CpG‐loaded nanorobots could effectively deliver CpG payloads to TLR‐9‐positive tumors and elicit anti‐tumor immunity through TLR9 signaling and autophagy. Therefore, besides being a commonly used adjuvant for tumor vaccination, CpG‐loaded nanorobots can effectively reprogram the tumor immunosuppressive microenvironment and suppress tumor growth and recurrence. This nanorobot‐based CpG immunotherapy can be considered a feasible approach to induce anti‐tumor immunity, showing great therapeutic potential for the future treatment of TLR9‐positive cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyImmunotherapyToll-Like Receptor 9NanostructuresAnimalsHumansMiceCell Line, TumorCpG IslandsNeoplasmsOligodeoxyribonucleotidesTumor Microenvironment

Stichwörter der Autor:innen

CpGTLR9autophagycancer immunotherapynanorobots

Substanzen

OligodeoxyribonucleotidesToll-Like Receptor 9

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, P. R. China.
  • School of Nanoscience and Technology, University of Chinese Academy of Sciences (UCAS), Beijing, 100149, P. R. China.
  • Institute of Bioengineering and Institute of Materials Science & Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
  • Lab of Functional and Biomedical Nanomaterials, College of Materials Science and Engineering, Qingdao University of Science and Technology (QUST), Qingdao, 266042, P. R. China.

ORCID-Profile: Yao-Xin Lin

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Programs of the Ministry of Science and Technology
  • National Center for Nanoscience and Technology and Chinese Academy of Sciences
  • Basic Research Cooperation Special Foundation of Beijing-Tianjin-Hebei

Zitieren

APA

Wang, Y., Qiao, S. L., Wang, J., Yu, M. Z., Wang, N. N., Mamuti, M., An, H. W., Lin, Y. X., & Wang, H. (2024). Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy. Advanced Materials. https://doi.org/10.1002/adma.202306248

Vancouver

Wang Y, Qiao SL, Wang J, Yu MZ, Wang NN, Mamuti M, et al. Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy. Advanced Materials. 2024. doi:10.1002/adma.202306248

BibTeX
@article{Wang2024,
  author = {Wang, Yi and Qiao, Sheng-Lin and Wang, Jie and Yu, Meng-Zhen and Wang, Nan-Nan and Mamuti, Muhetaerjiang and An, Hong-Wei and Lin, Yao-Xin and Wang, Hao},
  title = {Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202306248}
}
Kostenlos starten →